In its sixth annual MEDMARX Report, USP examined medication errors associated with radiological services. According to the report, 12% of all med errors reported to MEDMARX occurring in conjunction with radiological services were rated as harmful errors-seven times that seen in the general MEDMARX dataset of reported errors. Since more than 300 million diagnoses and treatments each year utilize radiological services, including radiology departments, cardiac catheterization laboratories, and nuclear medicine, USP hopes that the report will spur self-examination at institutions to identify weak links within each facility. However, the report has been criticized by the American College of Radiology as incomplete and inaccurate, and the college fears that the report may cause unnecessary alarm from patients.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration
March 27th 2024At APhA 2024, 2 posters looked into how collaboration between physicians and community pharmacists is crucial when it comes to opioid prescriptions, and current opioid use patterns among older adults.